InDex Pharmaceuticals gets patent for additional DIMS compounds granted in Europe |
| April 07, 2021 | April 2021 Bond Updates |
|
STOCKHOLM, April 7, 2021 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a patent covering 19 compounds from the company's DIMS platform has been granted by the European Patent Office. InDex has a preclinical portfolio of more than 150 DNA-based... |
| View more at: https://www.prnewswire.com:443/news-releases/index-pharmaceuticals-gets-patent-for-additional-dims-compounds-granted-in-europe-301263777.html |
| Related News |
|